Our immunohistochemical analysis of above CRC samples (n = 70) showed patients with lower CEA expression had more reduced survival than patients with higher CEA expression, though, maybe due to limited patient tumor sample number, there was no significant difference (Figure 1E). The gene discussed is CEACAM5; the disease is colorectal carcinoma.